Cargando…
A Bibliometric Analysis of the Oligometastatic State over the Last Two Decades: A Shifting Paradigm for Oncology? An AIRO Oligometastatic Study Group
SIMPLE SUMMARY: The concept of “oligometastatic state” has brought about a shift in our understanding of cancer’s metastasis and progression, and its management remains an active field of research, with ongoing efforts to develop new treatment options. The aim of the present study is to report a bib...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417037/ https://www.ncbi.nlm.nih.gov/pubmed/37568718 http://dx.doi.org/10.3390/cancers15153902 |
_version_ | 1785087924496236544 |
---|---|
author | Marvaso, Giulia Mastroleo, Federico Corrao, Giulia Zaffaroni, Mattia Vincini, Maria Giulia Borghetti, Paolo Cuccia, Francesco Federico, Manuela Montesi, Giampaolo Pontoriero, Antonio Franceschini, Davide Franzese, Ciro Scorsetti, Marta Jereczek-Fossa, Barbara Alicja |
author_facet | Marvaso, Giulia Mastroleo, Federico Corrao, Giulia Zaffaroni, Mattia Vincini, Maria Giulia Borghetti, Paolo Cuccia, Francesco Federico, Manuela Montesi, Giampaolo Pontoriero, Antonio Franceschini, Davide Franzese, Ciro Scorsetti, Marta Jereczek-Fossa, Barbara Alicja |
author_sort | Marvaso, Giulia |
collection | PubMed |
description | SIMPLE SUMMARY: The concept of “oligometastatic state” has brought about a shift in our understanding of cancer’s metastasis and progression, and its management remains an active field of research, with ongoing efforts to develop new treatment options. The aim of the present study is to report a bibliometric analysis of the oligometastatic disease/state to provide an overview of the topic. A total of 3304 documents were collected from 1995 to 2022. Among all keywords used by authors, the top three were oligometastases (19%), SBRT (18%), and radiation therapy (8%). In particular, a link can be observed between radiotherapy and topics of side-fields like immunotherapy and targeted therapies, representing an opportunity for further combinatorial studies in this setting. This bibliometric analysis represents a detailed summary of the most influential studies dealing with the oligometastatic state and sheds light on the area for the attention of researchers worldwide. ABSTRACT: The term “oligometastasis” represents a relatively novel idea, which denotes a condition characterized by cancer dissemination with a limited number of lesions (usually fewer than five). The aim of the present study is to report a bibliometric analysis of the oligometastatic disease/state, incorporating all relevant studies on the topic for more than 20 years. The research strategy included at least one the terms “Oligmetastases”, “Oligometastasis”, “Oligometastatic”, “Oligoprogression, “Oligoprogressive”, “Oligorecurrent”, or “Oligorecurrency” in the title, abstract, and/or keywords. All English-language documents from 1 January 1995 (the year of the earliest available document in Scopus) to 31 December 2022 were considered for the analysis. R code (R version 4.2.0) with R Studio (version 2022.12.0-353) and the Bibliometrix package (version 4.0.1) were used for the analysis. A total of 3304 documents, mainly articles (n = 2083, 63.0%) and reviews (n = 813, 24.6%), were collected from 1995 to 2022. The average annual growth rate of literature on the topic was 26.7%. Overall 15,176 authors published on the topic, with an average of eight authors/publication. From 1995, 69 countries contributed to the literature, with the USA and Italy being the top contributors. Among all keywords used by authors, the top three were oligometastases (19%), SBRT (18%), and radiation therapy (8%). Themes regarding “locoregional treatment”, “organ motion”, and “immunotherapy” were the most recent trend topics, mainly developed from 2019 to 2022, while “high-dose chemotherapy”, “whole-brain radiotherapy”, and “metastatic breast cancer” saw their main development during 2009–2018. Our study shows the exceptionally flourishing scientific production on the oligometastatic state, summarizing the most influential studies and highlighting the future developments and interests. This analysis will serve as a benchmark to identify this area for the attention of researchers worldwide and contribute to the increasing scientific work. |
format | Online Article Text |
id | pubmed-10417037 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-104170372023-08-12 A Bibliometric Analysis of the Oligometastatic State over the Last Two Decades: A Shifting Paradigm for Oncology? An AIRO Oligometastatic Study Group Marvaso, Giulia Mastroleo, Federico Corrao, Giulia Zaffaroni, Mattia Vincini, Maria Giulia Borghetti, Paolo Cuccia, Francesco Federico, Manuela Montesi, Giampaolo Pontoriero, Antonio Franceschini, Davide Franzese, Ciro Scorsetti, Marta Jereczek-Fossa, Barbara Alicja Cancers (Basel) Article SIMPLE SUMMARY: The concept of “oligometastatic state” has brought about a shift in our understanding of cancer’s metastasis and progression, and its management remains an active field of research, with ongoing efforts to develop new treatment options. The aim of the present study is to report a bibliometric analysis of the oligometastatic disease/state to provide an overview of the topic. A total of 3304 documents were collected from 1995 to 2022. Among all keywords used by authors, the top three were oligometastases (19%), SBRT (18%), and radiation therapy (8%). In particular, a link can be observed between radiotherapy and topics of side-fields like immunotherapy and targeted therapies, representing an opportunity for further combinatorial studies in this setting. This bibliometric analysis represents a detailed summary of the most influential studies dealing with the oligometastatic state and sheds light on the area for the attention of researchers worldwide. ABSTRACT: The term “oligometastasis” represents a relatively novel idea, which denotes a condition characterized by cancer dissemination with a limited number of lesions (usually fewer than five). The aim of the present study is to report a bibliometric analysis of the oligometastatic disease/state, incorporating all relevant studies on the topic for more than 20 years. The research strategy included at least one the terms “Oligmetastases”, “Oligometastasis”, “Oligometastatic”, “Oligoprogression, “Oligoprogressive”, “Oligorecurrent”, or “Oligorecurrency” in the title, abstract, and/or keywords. All English-language documents from 1 January 1995 (the year of the earliest available document in Scopus) to 31 December 2022 were considered for the analysis. R code (R version 4.2.0) with R Studio (version 2022.12.0-353) and the Bibliometrix package (version 4.0.1) were used for the analysis. A total of 3304 documents, mainly articles (n = 2083, 63.0%) and reviews (n = 813, 24.6%), were collected from 1995 to 2022. The average annual growth rate of literature on the topic was 26.7%. Overall 15,176 authors published on the topic, with an average of eight authors/publication. From 1995, 69 countries contributed to the literature, with the USA and Italy being the top contributors. Among all keywords used by authors, the top three were oligometastases (19%), SBRT (18%), and radiation therapy (8%). Themes regarding “locoregional treatment”, “organ motion”, and “immunotherapy” were the most recent trend topics, mainly developed from 2019 to 2022, while “high-dose chemotherapy”, “whole-brain radiotherapy”, and “metastatic breast cancer” saw their main development during 2009–2018. Our study shows the exceptionally flourishing scientific production on the oligometastatic state, summarizing the most influential studies and highlighting the future developments and interests. This analysis will serve as a benchmark to identify this area for the attention of researchers worldwide and contribute to the increasing scientific work. MDPI 2023-07-31 /pmc/articles/PMC10417037/ /pubmed/37568718 http://dx.doi.org/10.3390/cancers15153902 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Marvaso, Giulia Mastroleo, Federico Corrao, Giulia Zaffaroni, Mattia Vincini, Maria Giulia Borghetti, Paolo Cuccia, Francesco Federico, Manuela Montesi, Giampaolo Pontoriero, Antonio Franceschini, Davide Franzese, Ciro Scorsetti, Marta Jereczek-Fossa, Barbara Alicja A Bibliometric Analysis of the Oligometastatic State over the Last Two Decades: A Shifting Paradigm for Oncology? An AIRO Oligometastatic Study Group |
title | A Bibliometric Analysis of the Oligometastatic State over the Last Two Decades: A Shifting Paradigm for Oncology? An AIRO Oligometastatic Study Group |
title_full | A Bibliometric Analysis of the Oligometastatic State over the Last Two Decades: A Shifting Paradigm for Oncology? An AIRO Oligometastatic Study Group |
title_fullStr | A Bibliometric Analysis of the Oligometastatic State over the Last Two Decades: A Shifting Paradigm for Oncology? An AIRO Oligometastatic Study Group |
title_full_unstemmed | A Bibliometric Analysis of the Oligometastatic State over the Last Two Decades: A Shifting Paradigm for Oncology? An AIRO Oligometastatic Study Group |
title_short | A Bibliometric Analysis of the Oligometastatic State over the Last Two Decades: A Shifting Paradigm for Oncology? An AIRO Oligometastatic Study Group |
title_sort | bibliometric analysis of the oligometastatic state over the last two decades: a shifting paradigm for oncology? an airo oligometastatic study group |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417037/ https://www.ncbi.nlm.nih.gov/pubmed/37568718 http://dx.doi.org/10.3390/cancers15153902 |
work_keys_str_mv | AT marvasogiulia abibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup AT mastroleofederico abibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup AT corraogiulia abibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup AT zaffaronimattia abibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup AT vincinimariagiulia abibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup AT borghettipaolo abibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup AT cucciafrancesco abibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup AT federicomanuela abibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup AT montesigiampaolo abibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup AT pontorieroantonio abibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup AT franceschinidavide abibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup AT franzeseciro abibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup AT scorsettimarta abibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup AT jereczekfossabarbaraalicja abibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup AT marvasogiulia bibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup AT mastroleofederico bibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup AT corraogiulia bibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup AT zaffaronimattia bibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup AT vincinimariagiulia bibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup AT borghettipaolo bibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup AT cucciafrancesco bibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup AT federicomanuela bibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup AT montesigiampaolo bibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup AT pontorieroantonio bibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup AT franceschinidavide bibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup AT franzeseciro bibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup AT scorsettimarta bibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup AT jereczekfossabarbaraalicja bibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup |